INTRODUCING

RNhale was founded in 2023 as a spinoff from the highly decorated pharmaceutical technology chair at Ludwig-Maximilians-Universität in Munich. Our origins are deeply embedded in the pharmaceutical industry, emphasizing regulatory knowledge and market access, with a particular focus on the scalability of processes. The technology at the heart of our company has been developed and refined over decades at LMU, leading to the establishment of RNhale.

Our team, comprised of experts from academia and the industry, is dedicated to transforming pharmaceutical processes and practices.